The rising interest in GLP-1 agonists for diabetes has led to a debate about application forms : transdermal systems versus pills . Traditionally , GLP-1 therapies were solely available in pill form, but https://saaddqru228966.blogsumer.com/39881791/glp-1-skin-applications-vs-pills-what-right-for-you